Skip to Content
Health

Oncology is at a turning point

Download our POV2 MB pdf

From AI-powered early detection to personalized cancer vaccines, the oncology landscape is undergoing a radical transformation. Patients are no longer passive recipients of care—they expect clarity, empathy, and digital-first support.

In this new POV, Envisioning the future of oncology patient experience, Capgemini explores how life sciences leaders can meet rising expectations by designing seamless, human-centered experiences across the entire patient journey.

Whether it’s diagnosis, treatment or survivorship, the future lies in combining precision medicine with empathetic technology—and building trust at every step.

Capgemini is ready to help.

From strategy to execution, we make it real. We bring the tools, insights, and global expertise to reshape oncology care.

Download our POV

Meet our experts

Thorsten Rall

Thorsten Rall

Global Industry Lead Life Sciences, EVP
Since January 2023, Thorsten has been the Executive Vice President and Global Industry Lead for Life Sciences at Capgemini. Previously, he worked at Novartis in various senior roles. As Senior Vice President of Digital Transformation & Innovation, he led the digital function, developed and implemented high-risk, high-return strategic innovation initiatives, and was responsible for Business Development and partnerships in the digital space.
Som Sarangi

Som Sarangi

Technology and Consulting leader
Som is a seasoned technology and consulting leader with over two decades of experience in the Life Sciences Industry. Currently, he spearheads Capgemini’s global business relationship with a Top10 biopharma. He is passionate about leveraging technology and fostering innovation to enhance business performance and improve patient outcomes.
Anil Patil

Anil Patil

Senior Technology Client Partner
Anil Patil is a senior Technology Client Partner with nearly 30 years of experience in the Life Sciences and Manufacturing sector. He is recognized for building trusted executive relationships and delivering transformative, win-win solutions that address complex industry challenges. Anil has led multi-million dollar engagements—including a €1.5 billion partnership with a major pharmaceutical company—driving innovation, operational excellence, and sustained value for global clients. His proactive, collaborative approach positions Capgemini as a strategic advisor to Life Sciences organizations seeking growth and long-term success.